Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010
Revenue $140.5M
Cost of Revenue $67.5M
Gross Profit $73.0M
Gross Margin 51.9%
Operating Expenses
Research & Development $6.3M
SG&A Expense $13.5M
Operating Income $26.9M
Operating Margin 19.1%
Interest Expense
Pretax Income $27.3M
Income Tax Expense $9.8M
Net Income $17.5M
Net Margin 12.5%
EPS (Basic) $0.39
EPS (Diluted) $0.38
Shares Outstanding (Basic) 44.9M
Shares Outstanding (Diluted) 46.2M
Dividends Per Share
← Newer Page 3 of 3 Older →